| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,127 |
7,088 |
$375K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,648 |
6,122 |
$227K |
| J9271 |
Injection, pembrolizumab, 1 mg |
587 |
452 |
$184K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,697 |
1,000 |
$140K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,608 |
1,528 |
$81K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,347 |
759 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,562 |
7,192 |
$46K |
| 99215 |
Prolong outpt/office vis |
180 |
148 |
$18K |
| J0897 |
Injection, denosumab, 1 mg |
496 |
474 |
$17K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,559 |
1,384 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
565 |
313 |
$9K |
| 99233 |
Prolong inpt eval add15 m |
169 |
115 |
$8K |
| 99222 |
Initial hospital care, per day, moderate complexity |
190 |
188 |
$7K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
316 |
206 |
$7K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,984 |
1,206 |
$5K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
226 |
166 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
78 |
76 |
$3K |
| 94010 |
|
710 |
689 |
$2K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
267 |
115 |
$2K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
45 |
24 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
188 |
151 |
$1K |
| 96367 |
|
56 |
37 |
$986.31 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
39 |
28 |
$746.24 |
| 94726 |
|
107 |
103 |
$605.25 |
| J1453 |
Injection, fosaprepitant, 1 mg |
340 |
226 |
$587.52 |
| 94729 |
|
102 |
98 |
$465.72 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
32 |
13 |
$417.66 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
31 |
27 |
$390.18 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,176 |
1,238 |
$385.33 |
| 96160 |
|
55 |
54 |
$92.67 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,218 |
760 |
$51.87 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
336 |
183 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
385 |
312 |
$0.00 |
| J0185 |
Injection, aprepitant, 1 mg |
205 |
137 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
26 |
24 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
237 |
128 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
93 |
40 |
$0.00 |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
65 |
64 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
79 |
45 |
$0.00 |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
27 |
12 |
$0.00 |